| Ticker: OCOC | 4400 PGA Boulevard, Suite 300 | |
| Exchange: NASDAQ-Small Cap Market | Palm Beach Gardens, Florida 33410 | |
| Industry: Manufacturing | (561) 627-8121 |
| Type of Shares: | Class A Common Shares | Filing Date: | 8/16/96 | |
| U.S. Shares: | 1,200,000 | Offer Date: | 11/12/96 | |
| Non-U.S. Shares: | 0 | Filing Range: | $4.50 - $5.00 | |
| Primary Shares: | 1,200,000 | Offer Price: | $4.00 | |
| Secondary Shares: | 0 | Gross Spread: | $0.40 | |
| Offering Amount: | $5,700,000 | Selling: | $0.20 | |
| Expenses: | - | Reallowance: | ||
| Shares Out After: | 3,272,674 |
| Manager | Tier | Phone |
| RAF Financial Corporation | Lead Manager | (303) 860-1700 |
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 12/31/95 | 6/30/96 | 6/30/95 | 6/30/96 | ||
| Revenue: | $0.69 | $0.73 | $0.20 | Assets: | $2.34 |
| Net Income: | -$2.74 | -$1.01 | -$0.93 | Liabilities: | $3.27 |
| EPS: | -$1.55 | -$0.50 | -$0.54 | Equity: | -$0.93 |
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company is a marketing company organized to develop and commercialize new health and personal care products for the consumer market. The company's first products consist of two Ocurest eye care products utilizing a patented delivery system for dispensing ophthalmic drug solution into the eye . The company acquired the exclusive worldwide licensing rights to the Ocurest Delivery System from a then affiliate of the company in 1991. After three years of product development, the company began limited marketing in late 1994 of two over-the-counter eye drop products packaged in the delivery system. The products consist of Ocurest Redness Reliever Lubricant and Ocurest Tears Formula Lubricant. Ocurest Eye Drops utilize ophthalmic drug formulations owned by Bausch & Lomb Pharmaceutical, Inc. and are manufactured under a supply agreement with Bausch & Lomb at its pharmaceutical facility in Tampa, Florida. The company owns the molds used to produce parts for the Ocurest Delivery System and the manufacturing equipment which Bausch & Lomb operates to produce all Ocurest eye care products. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to pay for inventory acquisition and production equipment, to pay for expenses relating to national advertising and promotion of the company's products, and to repay certain indebtedness and accrued interest and for general corporate purposes. |
©1996 IPO Data Systems, Inc. - All rights reserved.